Exo Therapeutics raised $78 million in series B financing to develop a new strategy for drugging enzymes. Many drugs work by blocking target enzymes’ active sites, which perform reactions like ...
The immune system must maintain a delicate balance to defend against harmful threats while avoiding excessive inflammation. When this balance is disrupted, immune responses can contribute to ...
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert ...
Previous studies from the Boxer lab on other enzyme active sites had reported on the magnitude of electric fields but not on their directions. "We call this tool a two-directional probe because with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results